Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PAYONEER GLOBAL INC. (PAYO)

  • Business News
  • June 15, 2026, 12:00 UTC
  • 1
  • 1 comments

Nuvei to Acquire Payoneer for $2.75 Billion, Creating a Leading Global Platform for Local and Cross-Border Commerce

Market reaction Comment Full text

KOPPERS HOLDINGS INC. (KOP)

  • Business News
  • June 15, 2026, 11:55 UTC
  • 2
  • 1 comments

Koppers Announces Participation in Upcoming June Investor Conferences

Market reaction Comment Full text

JINKOSOLAR HOLDING CO., LTD. (JKS)

  • Business News
  • June 15, 2026, 11:55 UTC
  • 2
  • 1 comments

JinkoSolar Earns RETCs "Overall Highest Achiever" Award for the Seventh Consecutive Year

Market reaction Comment Full text

SIYATA MOBILE, INC. (CHAI)

  • Business News
  • June 15, 2026, 11:50 UTC
  • 2
  • 1 comments

Core AI Holdings Appoints John Clinton Haley Former Meta Leader to Advisory Board

Market reaction Comment Full text

BEAZER HOMES USA INC (BZH)

  • Business News
  • June 15, 2026, 11:45 UTC
  • 2
  • 1 comments

Beazer Homes Announces Proposed Offering of $400 Million of Senior Unsecured Notes Due 2032

Market reaction Comment Full text

PATTERN GROUP INC. (PTRN)

  • Business News
  • June 15, 2026, 11:38 UTC
  • 2
  • 1 comments

Pattern Announces Launch of Proposed Secondary Offering of Series A Common Stock

Market reaction Comment Full text

SEADRILL LIMITED COMMON SHARES (SDRL)

  • Business News
  • June 15, 2026, 11:35 UTC
  • 2
  • 1 comments

Seadrill Announces Private Offering of $600 Million Senior Notes

Market reaction Comment Full text

B. RILEY FINANCIAL, INC. (RILY)

  • Business News
  • June 15, 2026, 11:31 UTC
  • 1
  • 1 comments

BRC Group Holdings, Inc. Provides Update on SpaceX Carried Interest Position

Market reaction Comment Full text

INNOVEX INTERNATIONAL, INC. (INVX)

  • Business News
  • June 15, 2026, 11:31 UTC
  • 1
  • 1 comments

Innovex Enters Into Agreement to Acquire TCO Group

Market reaction Comment Full text

Aptose Biosciences Inc (APTO)

  • Business News
  • June 15, 2026, 11:30 UTC
  • 3
  • 1 comments

Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2026 EHA Congress in Oral Presentation

Market reaction Comment Full text
  • Previous
  • 1118
  • 1119
  • 1120
  • 1121
  • 1122
  • Next

Search

News categories

  • Technical Exchange News(13595)
  • Event(6229)
  • SEC News(354895)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(194995)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin